These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8633252)

  • 21. CPT-11 in gastrointestinal cancer.
    Bleiberg H
    Eur J Cancer; 1999 Mar; 35(3):371-9. PubMed ID: 10448285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: the European perspective.
    Bleiberg H; Cvitkovic E
    Eur J Cancer; 1996; 32A Suppl 3():S18-23. PubMed ID: 8943661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.
    Shimada Y; Yoshino M; Wakui A; Nakao I; Futatsuki K; Sakata Y; Kambe M; Taguchi T; Ogawa N
    J Clin Oncol; 1993 May; 11(5):909-13. PubMed ID: 8487053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.
    Pitot HC; Wender DB; O'Connell MJ; Schroeder G; Goldberg RM; Rubin J; Mailliard JA; Knost JA; Ghosh C; Kirschling RJ; Levitt R; Windschitl HE
    J Clin Oncol; 1997 Aug; 15(8):2910-9. PubMed ID: 9256135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CPT-11. The European experience.
    Armand JP; Terret C; Couteau C; Rixe O
    Ann N Y Acad Sci; 1996 Dec; 803():282-91. PubMed ID: 8993522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of colorectal cancer: CPT-11 (irinotecan), a therapeutic innovation.
    Cunningham D
    Eur J Cancer; 1996; 32A Suppl 3():S1-8. PubMed ID: 8943658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU).
    Van Cutsem E; Cunningham D; Ten Bokkel Huinink WW; Punt CJ; Alexopoulos CG; Dirix L; Symann M; Blijham GH; Cholet P; Fillet G; Van Groeningen C; Vannetzel JM; Levi F; Panagos G; Unger C; Wils J; Cote C; Blanc C; Hérait P; Bleiberg H
    Eur J Cancer; 1999 Jan; 35(1):54-9. PubMed ID: 10211088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of chemotherapy for advanced colorectal cancer: new opportunities.
    Bleiberg H
    Semin Oncol; 1996 Feb; 23(1 Suppl 3):42-50. PubMed ID: 8633253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of irinotecan as first-line chemotherapy for patients with advanced colorectal carcinoma.
    Fírvida JL; Irigoyen A; Vázquez-Estévez S; Díz P; Constenla M; Casal-Rubio J; Valladares-Ayerbes M; Castellanos J; Rodríguez R; Balcells M
    Cancer; 2001 Feb; 91(4):704-11. PubMed ID: 11241237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irinotecan in epithelial ovarian cancer.
    Gershenson DM
    Oncology (Williston Park); 2002 May; 16(5 Suppl 5):29-31. PubMed ID: 12109803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.
    Rowinsky EK; Grochow LB; Ettinger DS; Sartorius SE; Lubejko BG; Chen TL; Rock MK; Donehower RC
    Cancer Res; 1994 Jan; 54(2):427-36. PubMed ID: 8275479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capecitabine: a review.
    Walko CM; Lindley C
    Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of irinotecan in colorectal cancer.
    Saltz LB
    Curr Oncol Rep; 1999; 1(2):155-60. PubMed ID: 11122813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer.
    Karthaus M; Ballo H; Abenhardt W; Steinmetz T; Geer T; Schimke J; Braumann D; Behrens R; Behringer D; Kindler M; Messmann H; Boeck HP; Greinwald R; Kleeberg U
    Oncology; 2005; 68(4-6):326-32. PubMed ID: 16020959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical and clinical trials of topoisomerase inhibitors.
    Saijo N
    Ann N Y Acad Sci; 2000; 922():92-9. PubMed ID: 11193928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer].
    Sakata Y; Shimada Y; Yoshino M; Kambe M; Futatsuki K; Nakao I; Ogawa N; Wakui A; Taguchi T
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1039-46. PubMed ID: 8210255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA approves irinotecan as first-line therapy for colorectal cancer.
    Oncology (Williston Park); 2000 May; 14(5):652, 654. PubMed ID: 10853457
    [No Abstract]   [Full Text] [Related]  

  • 39. Irinotecan: toward clinical end points in drug development.
    Pazdur R
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):13-21. PubMed ID: 9726086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer.
    Cassinello J; López-Alvarez P; Martínez-Guisado A; Valladares M; Huidobro G; López R; Bohn U; Sevilla I; Ballesteros P; Jorge M; Pérez-Carrión R; Fernández JL; Dorta J
    Med Oncol; 2003; 20(1):37-43. PubMed ID: 12665683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.